Mammoth Biosciences

United States · 180 Employees
Mammoth Biosciences is a biotechnology company focused on leveraging its proprietary ultracompact CRISPR systems to develop long-term curative therapies, as well as other applications such as decentralized precision diagnostics. Founded by CRISPR pioneer and Nobel laureate Jennifer Doudna and Trevor Martin, Janice Chen, and Lucas Harrington, the company's ultracompact proteins are designed to enable in vivo gene editing in difficult to reach tissues utilizing both nuclease applications and new editing modalities beyond double stranded breaks, including base editing, gene writing, and epigenetic editing. The company is building out its pipeline of potential in vivo gene editing therapeutics and capabilities and has partnerships with leading pharmaceutical and biotechnology companies to broaden the reach of its innovative and proprietary technology. Mammoth's deep science and industry experience, along with a robust and differentiated intellectual property portfolio, have enabled the company to further its mission to transform the lives of patients and deliver on the full promise of CRISPR technologies.

概述

国家 United States
成立时间 2017
总部 1000 Marina Boulevard, Brisbane, California, USA, 94005
电话号码 +1 770-655-1937
网站 http://www.mammoth.bio
LinkedIn http://www.linkedin.com/company/mammothbio
Twitter https://twitter.com/mammothbiosci
Facebook https://facebook.com/mammothbiosci/
员工数 180
行业 research,
简介 Mammoth Biosciences is a biotechnology company focused on leveraging its proprietary ultracompact CRISPR systems to develop long-term curative therapies, as well as other applications such as decentralized precision diagnostics. Founded by CRISPR pioneer and Nobel laureate Jennifer Doudna and Trevor Martin, Janice Chen, and Lucas Harrington, the company's ultracompact proteins are designed to enable in vivo gene editing in difficult to reach tissues utilizing both nuclease applications and new editing modalities beyond double stranded breaks, including base editing, gene writing, and epigenetic editing. The company is building out its pipeline of potential in vivo gene editing therapeutics and capabilities and has partnerships with leading pharmaceutical and biotechnology companies to broaden the reach of its innovative and proprietary technology. Mammoth's deep science and industry experience, along with a robust and differentiated intellectual property portfolio, have enabled the company to further its mission to transform the lives of patients and deliver on the full promise of CRISPR technologies.

技术

Flywheel

Hosting

Gmail

Email Providers

Google Apps

Other

Google Tag Manager

Tag Management

Hubspot

Marketing Automation

Microsoft Office 365

Other

Mobile Friendly

Other

NetSuite

CMS

Remote

Other

Typekit

Fonts

Viewpoint

Contruction Management Platform

WordPress.org

CMS

reCAPTCHA

Captcha

常见问题

Mammoth Biosciences 在哪里?

Mammoth Biosciences 的总部位于 1000 Marina Boulevard, Brisbane, California, USA, 94005

Mammoth Biosciences 的电话号码是多少?

Mammoth Biosciences 的电话号码是 +1 770-655-1937

Mammoth Biosciences 的官方网站是什么?

Mammoth Biosciences 的公司官方网站是 http://www.mammoth.bio

Mammoth Biosciences 是做什么的?

Mammoth Biosciences 的业务有哪些?

Mammoth Biosciences 的年收入是多少?

Mammoth Biosciences 的收入是 5000000美元

Mammoth Biosciences 有多少员工?

Mammoth Biosciences 有 180 名员工

Mammoth Biosciences 属于哪个行业?

Mammoth Biosciences 从事以下行业: research

Mammoth Biosciences 使用什么技术?

Mammoth Biosciences 使用的一些流行技术包括: Flywheel,Gmail,Google Apps,Google Tag Manager,Hubspot,Microsoft Office 365,Mobile Friendly,NetSuite,Remote,Typekit,Viewpoint,WordPress.org,reCAPTCHA

如何联系 Mammoth Biosciences?

Mammoth Biosciences 联系信息: 电话号码:+1 770-655-1937， 网站:http://www.mammoth.bio， 邮箱：adr***@***.com

Mammoth Biosciences 的社交媒体链接是什么?

Mammoth Biosciences 领英：http://www.linkedin.com/company/mammothbio,fackbook：https://facebook.com/mammothbiosci/,twitte:https://twitter.com/mammothbiosci

Mammoth Biosciences 是一家上市公司吗?

不是

Mammoth Biosciences 的最后一轮融资是什么时候?

Mammoth Biosciences在2021-09-01T00:00:00.000+00:00结束了最后一轮融资,金额达150M$。

谁投资 Mammoth Biosciences?

Mammoth Biosciences 有 7 家投资者,包括 Redmile Group, Foresite Capital, Senator Investment Group, Sixth Street, Greenspring Associates, Mayfield, Decheng Capital, NFX, Plum Alley、Redmile Group, Foresite Capital, Amazon, Inc.、National Institutes of Health、Decheng Capital, Mayfield, NFX, Verily, Plum Alley, Pacific 8, aMoon、NFX Bio、Mayfield Fund, Tectonic Capital, 8VC, NFX、NFX。

管理层

Adriana Lemberg

VP Product Management

Antonio Maffia

Senior Scientist I

Sara Ansaloni

Senior Manager

Rachel Herder

Vice President of Intellectual Property and Associate General Counsel

James Broughton

Sr. Director, Diagnostics

员工

Cameron Coates

Principal Scientist

Byron Lam

Material Coordinator

Ishita Jain

Scientist

Emel Alpay

Scientist II

Graham Larue

Bioinformatics Scientist

外贸获客 查找关键决策人

10亿+海关交易数据，1.2亿企业数据，2亿+企业联系人数据，1000千万真实采购商。覆盖200+个国家及地区，95%外贸重点拓展市场，可根据行业、经营范围等多方位挖掘目标客户。
免费试用

Top-ranked on G2 Crowd

全球B2B企业库 海关贸易数据 展会采购数据

工作更少，成就更大，销售更聪明

查找更多 B2B 联系人，丰富并验证记录
Email Address

全球B2B企业库

海关贸易数据

展会采购数据

Top-ranked on G2 Crowd

OR
Sign Up with Google